Delivery Order SPE2DB22D2206-SPE2DB24FFR21
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product Herceptin Hylecta 600mg-10,000 5ml. The contract has a firm fixed price ceiling value of $10,669.36 and an ultimate completion date of May 30, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $7,068.24 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide HERCEPTIN 150 MG VIALS. The delivery order is part of Amerisourcebergen Drug Corp's larger, single-award indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract...
- The U.S. government has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,942,502 units of Herceptin 150 mg vials. The contract has a ceiling value of $8,835.30 and a period of performance through April 2, 2024. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, which supports the Department of Defense's military treatment programs and facilities. Amerisourcebergen Drug...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the prime contractor, for the provision of 150 mg vials of the pharmaceutical drug Herceptin. The delivery order has a completion date of March 22, 2024 and a potential value of $8,835.30. Amerisourcebergen Drug Corp, a for-profit organization, is a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution...
- This federal contract award is for the delivery of Herceptin Hylecta 600mg-10,000 5ml to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $8,223.27 and a completion date of September 22, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated with any set-aside requirements, indicating it was awarded...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of HERCEPTIN 150 MG VIALS. The contract is a Delivery Order with a Firm Fixed Price of $2,670.42 and a performance period extending until July 30, 2025. It was awarded on July 9, 2025 by the Defense Logistics Agency (DLA), which serves as the Defense or Civilian agency for this contract. The contract is not set aside and is open to full and...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,681.68, is for the delivery of HERCEPTIN 150 MG VIALS. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HERCEPTIN 150 MG VIALS, a prescription medication, with a ceiling value of $21,363.36 and a completion date of July 22, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This contract award to AmerisourceBergen Drug Corp is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical under an Indefinite Delivery Contract (IDC). The $17,670.60 firm fixed-price contract is for the delivery of Herceptin 150 mg vials, a specialty pharmaceutical used to treat certain types of breast cancer. The contract has an ultimate completion date of January 31, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 IDC with the...
- This federal contract award, valued at $5,301.18, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,564,912,337 units of the pharmaceutical product Herceptin (150 mg vials) with a completion date of July 9, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFR21Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of HERCEPTIN HYLECTA 600MG-10,000 5ML. The contract has a potential value of $10,669.36 and a performance period through March 8, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order, which is not associated with any set-aside designation. This contract is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.7k | 2/15/24 |